Cargando…
Effects of Adjuvant Medications on A1C, Body Mass Index, and Insulin Requirements among Patients with Type 1 Diabetes
Randomized controlled trials have demonstrated that noninsulin medications used to treat type 2 diabetes can improve health outcomes among patients with type 1 diabetes (T1D). This study assessed the effects of adjuvant diabetes medications on glycated hemoglobin (A1C), body mass index (BMI), or tot...
Autores principales: | Silva Almodóvar, Armando, Clevenger, Jonathan, Nahata, Milap C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412392/ https://www.ncbi.nlm.nih.gov/pubmed/36005937 http://dx.doi.org/10.3390/pharmacy10040097 |
Ejemplares similares
-
Telehealth Intervention to Improve Uptake of Evidence-Based Medications among Patients with Type 2 Diabetes and Heart Failure or Cardiovascular Disease
por: Silva-Almodóvar, Armando, et al.
Publicado: (2023) -
Clinical Utility of Medication-Based Risk Scores to Reduce Polypharmacy and Potentially Avoidable Healthcare Utilization
por: Silva-Almodóvar, Armando, et al.
Publicado: (2022) -
High opioid doses, naloxone, and central nervous system active medications received by Medicare‐enrolled adults
por: Silva Almodóvar, Armando, et al.
Publicado: (2022) -
Implementing Clinical Decision Support Tools and Pharmacovigilance to Reduce the Use of Potentially Harmful Medications and Health Care Costs in Adults With Heart Failure
por: Silva Almodóvar, Armando, et al.
Publicado: (2021) -
Medication Adherence in Medicare-Enrolled Older Adults with Chronic Obstructive Pulmonary Disease before and during the COVID-19 Pandemic
por: Liu, Ligang, et al.
Publicado: (2022)